
advesya
advesya
- Biotech
- Building: B2
Advesya aims to develop and commercialise CAR-T cell therapies

AlloCyte Pharmaceuticals AG
AlloCyte Pharmaceuticals AG
- Biotech
- Building: C
AlloCyte Pharmaceuticals is a Swiss-based biopharmaceutical company.

Amporin Pharmaceuticals AG
Amporin Pharmaceuticals AG
- Biotech
- Building: C
Amporin Pharmaceuticals AG is a new biotech startup founded in Basel 2024 by a small team of industry-seasoned drug development experts. We are developing a breakthrough new class of small molecule drugs that can protect and repair cell membranes as the first potential acute oral disease-modifying treatments for deadly degenerative diseases associated with protein misfolding and aggregation. Our vision is to cure 6 degenerative diseases with a simple pill, starting with Parkinson’s disease and ALS, while our preliminary animal data suggests that this is already possible.

Anaveon AG
Anaveon AG
- Biotech
- Building: C4
Anaveon is a clinical stage company committed to transforming immunological insights into life-saving therapies.

ARTIDIS AG
ARTIDIS AG
- Medtech
- Building: B8
ARTIDIS AG, development and commercialization of ARTIDIS (Automated And Reliable Tissue Diagnostics).

BioVersys AG
BioVersys AG
- Biotech
- Building: C3
BioVersys switches off bacterial drug resistance, thus reactivating approved antibiotics.

Ccloop
Ccloop
- Building: C
Proactive climate management is crucial for the sustainable development of our planet. ccloop is committed to decoupling raw material streams used in the production of daily life goods from fossil resources (such as oil, gas, and coal). This process is commonly known as defossilisation.

Cellestia Biotech AG
Cellestia Biotech AG
- Biotech
- Building: B2
Cellestia is a clinical stage R&D company.

Cimeio Therapeutics AG
Cimeio Therapeutics AG
- Biotech
- Building: F
Cimeio is an applied gene editing, cellular, and immunotherapy company.

Di Meliora AG
Di Meliora AG
- Medtech
- Building: C1
Di Meliora AG is active in manufacture of medical and dental instruments and supplies.

Edelweiss Connect GmbH
Edelweiss Connect GmbH
- Service Provider
- Building: B3
Edelweiss Connect manages collaborative projects.

fgen / GINKGO BIOWORKS
fgen / GINKGO BIOWORKS
- Biotech
- Building: B3
FGen is a service provider for biotechnology, life-sciences, and industry.

FimmCyte AG
FimmCyte AG
- Biotech
- Building: B2
Towards a Disease Modifying Treatment for Endometriosis.

Granite Bio AG
Granite Bio AG
- Biotech
- Building: B
Targeting fundamentals of inflammation, autoimmunity and fibrosis

intilaris LifeSciences GmbH
intilaris LifeSciences GmbH
- Service Provider
- Building: C1
Intilaris LifeSciences is a consulting and service company

mAbTree Biologics
mAbTree Biologics
- Biotech
- Building: C
Our core purpose is to create and develop novel and targeted antibodies to improve the lives of patients with cancer and autoimmune disorders.

metaLead Therapeutics AG
metaLead Therapeutics AG
- Building: C
metaLead AG is a preclinical stage biotech startup aiming to revolutionize the way we treat metal-related diseases, currently focusing on Wilson's disease.

MOMM Diagnostics GmbH
MOMM Diagnostics GmbH
- Medtech
- Building: B2
MOMM develops high-sensitivity rapid diagnostic tests.

MT-act
MT-act
- Biotech
- Building: C
"MT-act is a preclinical stage spin-off company, stemming from a CNRS research institute dedicated to cutting-edge biological sciences and understanding of human pathophysiology. We develop class compounds to treat human pathologies that share a common molecular defect; dysfunction of the microtubular network. The company roots on a unique platform technology providing chemical versatility to develop first-in-class drugs that serve multiple development programs. Employing a knowledge-based view, MT-act develops drug candidates to correct microtubule dysfunctions. The choice of the targeted mode of action is highly differentiated."

Myria Biosciences
Myria Biosciences
- Building: C4
Myria Biosciences pioneers a new class of therapeutic molecules that combine the most important features of small molecules and biologics.

NBE-Therapeutics AG
NBE-Therapeutics AG
- Biotech
- Building: B2
NBE-Therapeutics is focused on the development of novel antibody-based therapeutics.

Ridgeline Discovery GmbH
Ridgeline Discovery GmbH
- Accelerator
- Building: F
Ridgeline is a Versant Ventures Discovery Engine.

Serac Biosciences AG
Serac Biosciences AG
- Biotech
- Building: C7
Zweck der Gesellschaft ist die Erforschung, die Entwicklung, die Herstellung, die Verwertung, der Erwerb und der Vertrieb von pharmazeutischen Produkten und Technologien.

SixPeaks Bio AG
SixPeaks Bio AG
- Biotech
- Building: B
Die Gesellschaft bezweckt die Erforschung, die Entwicklung, die Herstellung, die Verwertung, den Erwerb und den Vertrieb von pharmazeutischen und diagnostischen Produkten und Technologien

Stromal Therapeutics AG
Stromal Therapeutics AG
- Biotech
- Building: C
Stromal Therapeutics AG is a Swiss biotech company.

TargImmune Therapeutics AG
TargImmune Therapeutics AG
- Biotech
- Building: C4, F
TargImmune is developing a novel cancer-targeted platform.
Tech Park Basel
Tech Park Basel
- Service Provider
- Building: C1
The Tech Park Basel provides spin-offs and early-stage technology-oriented start-ups.

TECregen AG
TECregen AG
- Biotech
- Building: B
TECregen is a biotechnology company

TOLREMO therapeutics AG
TOLREMO therapeutics AG
- Biotech
- Building: C2
Resistance-preventing precision therapies to patients with cancer.

VAXIMM AG
VAXIMM AG
- Biotech
- Building: C2
VAXIMM developing oral T-cell immunotherapies for patients suffering from cancer.

Versameb AG
Versameb AG
- Biotech
- Building: B8
Versameb is a Swiss based biotechnology platform company